Menopause hormone patches are in short supply. What are they? And how do they compare with other therapies?
When patients can’t access their MHT patches, they may consider switching to different formulations, such as tablets or gels.
Type 1 diabetes: Hybrid closed-loop and open-loop systems therapies compared
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Corewell reverses decision on starting treatments for trans minors
Corewell Health said it has reversed its decision, and will start new gender-affirming therapies for transgender minors.
Dual-target drug may lead to new treatment approach for breast cancer patients
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
News Medical10h
New discovery could overcome immune therapy failure in ovarian cancer
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
Cure Today13h
An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.